Key result
Direct implantation of the Edwards SAPIEN XT valve without prior balloon valvuloplasty was feasible and safe in 10 selected patients, with 0% adverse events at 30 days.
Why the study?
Does direct implantation of Edwards SAPIEN XT without prior balloon valvuloplasty prevent adverse events in patients with symptomatic severe aortic stenosis?
Population
n=10 patients with symptomatic severe aortic stenosis of a native valve and high surgical risk, selected…
Design
Case_series
Follow-up
30 days
Authors
Loading...
May support direct SAPIEN XT implantation in selected AS patients; hypothesis-generating and should not yet change practice.
Observational (n=10)
Does direct implantation of Edwards SAPIEN XT without prior balloon valvuloplasty prevent adverse events in patients with symptomatic severe aortic stenosis?
Direct transfemoral implantation of the balloon-expandable Edwards SAPIEN XT valve without prior balloon valvuloplasty is feasible and safe in highly selected patients with severe aortic stenosis.
Garcı́a et al. (2013) conducted an observational in Symptomatic aortic stenosis of a native valve and high surgical risk (n=10). Direct implantation of Edwards SAPIEN XT prosthesis without balloon valvuloplasty was evaluated on Adverse events (death, need for pacemaker, myocardial infarction, or stroke). Direct implantation of the Edwards SAPIEN XT valve without prior balloon valvuloplasty was feasible and safe in 10 selected patients, with 0% adverse events at 30 days.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: